Wlodarski K, Tajber L, Sawicki W
Medical University of Gdansk, Department of Physical Chemistry, Hallera 107, 80-416 Gdansk, Poland.
Trinity College Dublin, School of Pharmacy and Pharmaceutical Sciences, College Green, Dublin 2, Ireland.
Eur J Pharm Biopharm. 2016 Dec;109:14-23. doi: 10.1016/j.ejpb.2016.09.011. Epub 2016 Sep 20.
The aim of this research was to develop immediate release tablets comprising solid dispersion (IRSDTs) of tadalafil (Td) in a vinylpyrrolidone and vinyl acetate block copolymer (PVP-VA), characterized by improved dissolution profiles. The solid dispersion of Td in PVP-VA (Td/PVP-VA) in a weight ratio of 1:1 (w/w) was prepared using two different processes i.e. spray drying and ball milling. While the former process has been well established in the formulation of IRSDTs the latter has not been exploited in these systems yet. Regardless of the preparation method, both Td/PVP-VA solid dispersions were amorphous as confirmed by PXRD, DSC and FTIR. However, different morphology of particles (SEM) resulted in differences in water apparent solubility and disk intrinsic dissolution rate (DIDR). Both solid dispersions and crystalline Td were successfully made into directly compressible tablets at three doses of Td, i.e. 2.5mg, 10mgand20mg, yielding nine different formulations (D-D). Each of the lots met the requirements set by Ph.Eur. and was evaluated with respect to appearance, diameter, thickness, mass, hardness, friability, disintegration time and content of Td. IRSDTs performed as supersaturable formulations and had significantly improved water dissolution profiles in comparison with equivalent tablets containing crystalline Td and the marketed formulations. Tablets with both spray dried and ball milled Td/PVP-VA revealed the greatest improvement in dissolution depending on the investigated doses, i.e. 2.5mgand20mg, respectively. Also, dissolution of Td from Td/PVP-VA delivered in different forms occurred in the following order: powders>tablets>capsules.
本研究的目的是开发由他达拉非(Td)在乙烯基吡咯烷酮和醋酸乙烯酯嵌段共聚物(PVP-VA)中的固体分散体组成的速释片(IRSDTs),其特征在于具有改善的溶出曲线。采用喷雾干燥和球磨两种不同工艺制备了重量比为1:1(w/w)的Td在PVP-VA中的固体分散体(Td/PVP-VA)。虽然前一种工艺在IRSDTs的制剂中已得到充分确立,但后一种工艺尚未在这些体系中得到应用。无论制备方法如何,通过PXRD、DSC和FTIR证实,两种Td/PVP-VA固体分散体均为无定形。然而,颗粒的不同形态(SEM)导致水表观溶解度和圆盘固有溶出速率(DIDR)存在差异。在三种Td剂量,即2.5mg、10mg和20mg下,成功地将固体分散体和结晶Td制成直接压片,得到九种不同的制剂(D-D)。每一批次均符合欧洲药典规定的要求,并对外观、直径、厚度、质量、硬度、脆碎度、崩解时间和Td含量进行了评估。IRSDTs表现为过饱和制剂,与含有结晶Td的等效片剂和市售制剂相比,其水溶解曲线有显著改善。含有喷雾干燥和球磨Td/PVP-VA的片剂根据所研究的剂量,即分别为2.5mg和20mg,显示出最大的溶出改善。此外,以不同形式递送的Td/PVP-VA中Td的溶出顺序如下:粉末>片剂>胶囊。